Nitin Pal Kalia (Nitin P Kalia)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Emergency Department

Methicillin Resistant Staphylococcus Aureus

Mycobacterium Tuberculosis

Top Venues

RSC medicinal chemistry

Applied sciences (Basel, Switzerland)

Microbiology spectrum

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Pallavi Saha, Shashikanta Sau, Nitin Pal Kalia, Deepak K Sharma
Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase. RSC medicinal chemistry 15 (5) (2024)
Pallavi Saha, Samarpita Das, Harish K Indurthi, Rohit Kumar, Arnab Roy, Nitin Pal Kalia, Deepak K Sharma
Cytochrome bd oxidase: an emerging anti-tubercular drug target. RSC medicinal chemistry 15 (3) (2024)
Pallavi Saha, Shashikanta Sau, Nitin Pal Kalia, Deepak K Sharma
Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase. RSC medicinal chemistry 15 (5) (2024)
Pallavi Saha, Samarpita Das, Harish K Indurthi, Rohit Kumar, Arnab Roy, Nitin Pal Kalia, Deepak K Sharma
Cytochrome bd oxidase: an emerging anti-tubercular drug target. RSC medicinal chemistry 15 (3) (2024)
Pavan Kumar Nagdev, Puja Kumari Agnivesh, Arnab Roy, Shashikanta Sau, Nitin Pal Kalia
Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, Wee Han Poh, Dennis Litty, Nitin Pal Kalia, Simon Larsson, Amaravadhi Harikishore, Scott A Rice, Philip W Ingham, Volker Müller, Garrett C Moraski, Marvin J Miller, Thomas Dick, Kevin Pethe, Gerhard Grüber
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiology spectrum (2023)
Ojaswitha Ommi, Mohammad Naiyaz Ahmad, Siva Nageswara Rao Gajula, Parita Wanjari, Shashikanta Sau, Puja Kumari Agnivesh, Santosh Kumar Sahoo, Nitin Pal Kalia, Rajesh Sonti, Srinivas Nanduri, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis . RSC medicinal chemistry 14 (7) (2023)
Sarah M Hopfner, Bei Shi Lee, Nitin Pal Kalia, Marvin J Miller, Kevin Pethe, Garrett C Moraski
Syntheses and Structure-Activity Relationships of N -Phenethyl-Quinazolin-4-yl-Amines as Potent Inhibitors of Cytochrome bd Oxidase in Mycobacterium tuberculosis . Applied sciences (Basel, Switzerland) 11 (19) (2021)
Sarah M Hopfner, Bei Shi Lee, Nitin Pal Kalia, Marvin J Miller, Kevin Pethe, Garrett C Moraski
Syntheses and Structure-Activity Relationships of N -Phenethyl-Quinazolin-4-yl-Amines as Potent Inhibitors of Cytochrome bd Oxidase in Mycobacterium tuberculosis . Applied sciences (Basel, Switzerland) 11 (19) (2021)
Sarah M Hopfner, Bei Shi Lee, Nitin Pal Kalia, Marvin J Miller, Kevin Pethe, Garrett C Moraski
Syntheses and Structure-Activity Relationships of N -Phenethyl-Quinazolin-4-yl-Amines as Potent Inhibitors of Cytochrome bd Oxidase in Mycobacterium tuberculosis . Applied sciences (Basel, Switzerland) 11 (19) (2021)
Sarah M Hopfner, Bei Shi Lee, Nitin Pal Kalia, Marvin J Miller, Kevin Pethe, Garrett C Moraski
Syntheses and Structure-Activity Relationships of N -Phenethyl-Quinazolin-4-yl-Amines as Potent Inhibitors of Cytochrome bd Oxidase in Mycobacterium tuberculosis . Applied sciences (Basel, Switzerland) 11 (19) (2021)